Skip to main content
. 2020 Jul 16;7(4):328–337. doi: 10.1016/j.wjorl.2020.05.010

Table 2.

Characteristics of studies included – head and neck surgery.

Study Type of Study Participants Surgical technique TXA Administration Timing of TXA dose Control Primary Outcome Main result
Das, 2015 Randomized controlled trial T: 40
C: 40
Unilateral H&N cancer surgeries (modified radical supraomohyoid, posterolateral neck dissection) 20 mg/kg IV 15 min before anaesthetic induction IV saline 1. Intraoperative blood loss (ml)
2. Red cell concentrate transfusion requirements (units)
1. T: 52.34 ± 10.2, C 110.24 ± 13.4 (p = 0.0001)
2. T: 8, C: 42 p < 0.0001
Kulkarni, 2016 Randomized controlled trial T: 108
C: 111
Composite resection of mandible + neck dissection + pedicled flaps (single or double) 10 mg/kg IV 20 min after anaesthetic induction IV saline Intraoperative blood loss (ml) T: 750, C: 780 p = 0.22
Chen, 2008 Randomized controlled trial T: 26
C: 29
Modified radical neck dissection, Hemithyroidectomy, Superficial parotidectomy 10 mg/kg IV + 1 mg/kg/h IV Preoperative + intraoperative IV saline 1. Drainage tube placement duration (h)
2. Drainage amount (ml)
1. T: 2.69 ± 0.68, C: 3.07 ± 1.13 (p = 0.146)
2. T: 49.7 ± 32.6, C: 88.8 ± 89.9 (p = 0.041)

C: control group, T: trial/intervention group, IV: intravenous.